Losan Pharma GmbH Sustainability Profile
Losan Pharma GmbH, a prominent player in the pharmaceutical industry, is headquartered in Germany and operates extensively across Europe. Founded in 1998, the company has established itself as a leader in the development and manufacturing of high-quality generic pharmaceuticals and specialty products. Losan Pharma focuses on areas such as oncology, cardiology, and infectious diseases, offering a diverse portfolio that includes both prescription medications and over-the-counter solutions. Their commitment to innovation and quality has earned them a strong market position, with notable achievements in regulatory compliance and product development. With a reputation for excellence, Losan Pharma continues to advance healthcare solutions, making significant contributions to patient care and the pharmaceutical landscape.
DitchCarbon Score
How does Losan Pharma GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Losan Pharma GmbH's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Losan Pharma GmbH's reported carbon emissions
Losan Pharma GmbH, headquartered in Germany, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is classified as a current subsidiary and does not inherit emissions data from a parent organization. In terms of climate commitments, there are no documented reduction targets or initiatives such as Science-Based Targets (SBTi) or other climate pledges. This lack of data suggests that Losan Pharma GmbH may still be in the early stages of developing a comprehensive climate strategy or reporting framework. As the pharmaceutical industry increasingly focuses on sustainability, it is essential for companies like Losan Pharma GmbH to establish clear emissions reduction goals and transparent reporting practices to align with global climate initiatives.
How Carbon Intensive is Losan Pharma GmbH's Industry?
How Carbon Intensive is Losan Pharma GmbH's Location?
Losan Pharma GmbH's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Losan Pharma GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
